 | Up a level |
Christoph, D. C. C., Rizzo, F., Kambartel, K-O., Winke, S., Panse, J., Abdulla, D. S., Scheffler, M., Azeh, I. T., Hoiczyk, M., Turki, A. and Metzenmacher, M. (2020). Docetaxel/nindetanib as efficient treatment option after failure of immune checkpoint inhibition: Real-world evidence. Ann. Oncol., 31. S. S876 - 1. AMSTERDAM: ELSEVIER. ISSN 1569-8041
Sebastian, M., Reck, M., Fischer, R. N., Christoph, D. C. C., Bernhardt, C., von der Heyde, E., Nusch, A., Ludwig, P., Hipper, A., Hanselmann, J., Medinger, T., Binninger, A., Jaenicke, M., Christopoulos, P., Elender, C., Bethge, A., Seese, B., Gauler, T. C. and Waller, C. (2022). First real-world outcome data of SCLC in Germany: Data from the Clinical Research platform Into molecular testing, treatment and outcome of (non-)Small cell lung carcinoma Patients (CRISP; AIO-TRK-0315). Ann. Oncol., 33 (7). S. S1252 - 1. AMSTERDAM: ELSEVIER. ISSN 1569-8041